Plasma ghrelin and pro-inflammatory markers in patients with obstructive sleep apnea and stable coronary heart disease

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 251-256

  Yang, Dan ^a   Liu, Zhihong ^a   Luo, Qin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

CHD; Ghrelin; IL 6; OSA; TNF

Indexed keywords

GHRELIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FEMALE; GENSINI SCORE; HUMAN; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NECK CIRCUMFERENCE; SLEEP DISORDERED BREATHING; WAIST CIRCUMFERENCE;

EID: 84876851751     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883874     Document Type: Article

References (28)

1. Young T, Palta M, Dempsey J et al: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med, 1993; 328: 1230-35
2. Hermann DM, Bassetti CL: Sleep-disordered breathing and stroke. Curr Opin Neurol, 2003; 16: 87-90
3. Shahar E, Whitney CW, Redline S et al: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med, 2001; 163: 19-25
4. Kim SM, Cho KI, Kwon JH et al: Impact of obstructive sleep apnea on left atrial functional and structural remodeling beyond obesity. J Cardiol, 2012; 60(6): 475-83
5. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005; 352: 1685-95
6. Somers VK, White DP, Amin R et al: Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation, 2008; 118: 1080-111
7. Cummings DE, Weigle DS, Frayo RS et al: Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. N Engl J Med, 2002; 346: 1623-30
8. Wren AM, Seal LJ, Cohen MA et al: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab, 2001; 86: 5992
9. Harsch IA, Konturek PC, Koebnick C et al: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J, 2003; 22: 251-57
10. Kotani K, Sakane N, Saiga K et al: Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome. Arch Med Res, 2006; 37: 903-6
11. Li WG, Gavrila D, Liu X et al: Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation, 2004; 109: 2221-26
12. Tesauro M, Schinzari F, Iantorno M et al: Ghrelin improves endothelial functionin patients with metabolic syndrome. Circulation, 2005; 112: 2986-92
13. Dixit VD, Schaffer EM, Pyle RS et al: Ghrelin inhibits leptin- and activationinduced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest, 2004; 114: 57-66
14. Hattori N: Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm IGF Res, 2009; 19: 187-97
15. Taub DD, Murphy WJ, Longo DL: Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr Opin Pharmacol, 2010; 10: 408-24
16. Tsara V, Serasli E, Amfilochiou A et al: Greek version of the Epworth Sleepiness Scale. Sleep Breath, 2004; 8: 91-95
17. Gensini GG: A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983; 51: 606
18. Epstein LJ, Kristo D, Strollo PJ Jr et al: Clinical Guideline for the Evaluation, anagement and Long-term Care of Obstructive Sleep Apnea in Adults. J Clin Sleep Med, 2009; 5: 263-76
19. Yokoe T, Minoguchi K, Matsuo H et al: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 2003; 107: 1129-34
20. Liu H, Liu J, Xiong S et al: The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ, 2000; 20: 200-2
21. Ciftci TU, Kokturk O, Bukan N, Bilgihan A: The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine, 2004; 28: 87-91
22. Ridker PM, Rifai N, Pfeffer M et al: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation, 2000; 101: 2149-53
23. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 2000; 101: 1767-72
24. Takahashi K, Chin K, Akamizu T et al: Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment. Respirology, 2008; 13: 810-16
25. Ursavas A, Ilcol YO, Nalci N et al: Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: Role of obesity. Ann Thorac Med, 2010; 5: 161-65
26. Kadoglou NP, Lampropoulos S, Kapelouzou A et al: Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease - KOZANI STUDY. Transl Res, 2010; 155: 238-46
27. Rodríguez A, Gómez-Ambrosi J, Catalán V et al: The ghrelin O-acyltransferaseghrelin system reduces TNF-αlpha-induced apoptosis and autophagy in human visceral adipocytes. Diabetologia, 2012; 55(11): 3038-50
28. Pou KM, Massaro JM, Hoffmann U et al: Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation, 2007; 116: 1234-41